The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors
Open accessAbstract
In search of novel genes expressed in metastatic prostate cancer, we subtracted cDNA isolated from benign prostatic hypertrophic tissue from cDNA isolated from a prostate cancer xenograft model that mimics advanced disease. One novel gene that is highly expressed in advanced prostate cancer encodes a 339-amino acid protein with six potential membrane-spanning regions flanked by hydrophilic amino- and carboxyl-terminal domains. This structure suggests a potential function as a channel or transporter protein. This gene, named STEAP for s ix- t ransmembrane e pithelial a ntigen of the p rostate, is expressed predominantly in human prostate tissue and is up-regulated in multiple cancer cell lines, including prostate, bladder, colon, ovarian, and Ewing sarcoma. Immunohistochemical analysis of clinical specimens demonstrates significant STEAP expression at the cell–cell junctions of the secretory epithelium of prostate and prostate cancer cells. Little to no staining was detected at the plasma membranes of normal, nonprostate human tissues, except for bladder tissue, which expressed low levels of STEAP at the cell membrane. Protein analysis located STEAP at the cell surface of prostate-cancer cell lines. Our results support STEAP as a cell-surface tumor-antigen target for prostate cancer therapy and diagnostic imaging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diatchenko, L., Lau, Y. F., Campbell, A. P., Chenchik, A., Moqadam, F., Huang, B., Lukyanov, S., Lukyanov, K., Gurskaya, N., Sverdlov, E. D., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6025 · Cited by 3,010
Production of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
LNCaP model of human prostatic carcinoma.
Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H. E., Chu, T. M., MIRAND, E. A., & Murphy, G. P. (1983) · PubMed · Cited by 1,789
Maloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T.-M., Dallaire, B. K., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2188 · Cited by 1,733
(1997) · PubMed · Cited by 1,541
Ross, J. S., & Fletcher, J. A. (1998) · STEM CELLS · doi:10.1002/stem.160413 · Cited by 985
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
Reiter, R. E., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1735 · Cited by 673
Whang, Y. E., Wu, X., Suzuki, H., Reiter, R. E., Tran, C., Vessella, R. L., Said, J. W., Isaacs, W. B., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5246 · Cited by 639
Expression of the prostate-specific membrane antigen.
Israeli, R., Powell, C. T., Corr, J., Fair, W. R., & Heston, W. D. W. (1994) · PubMed · Cited by 601
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.
Israeli, R., Powell, C. T., Fair, W. R., & Heston, W. D. W. (1993) · PubMed · Cited by 541
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi, T., Kallioniemi, A. H., Syvänen, A. C., HYYTINEN, E.-R., Karhu, R., Tammela, T. L. J., Isola, J. J., & Kallioniemi, O. (1995) · PubMed · Cited by 480
Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R., & Bander, N. H. (1998) · PubMed · Cited by 458
The three-dimensional structure of aquaporin-1
Walz, T., Hirai, T., Murata, K., Heymann, J. B., Mitsuoka, K., Fujiyoshi, Y., Smith, B. L., Agre, P., & Engel, A. (1997) · Nature · doi:10.1038/42512 · Cited by 457
Klein, K. A., Reiter, R. E., Redula, J., Moradi, H., Zhu, X. L., Brothman, A. R., Lamb, D. J., Marcelli, M., Belldegrun, A., Witte, O. N., et al. (1997) · Nature Medicine · doi:10.1038/nm0497-402 · Cited by 399
Muller, A. J., Young, J. C., Pendergast, A. M., Pondel, M., Landau, N. R., Littman, D. R., & Witte, O. N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1785 · Cited by 377
Carter, R. E., Feldman, A. R., & Coyle, J. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.749 · Cited by 372
A method for constructing radiation hybrid maps of whole genomes
Walter, M. A., Spillett, D. J., Thomas, P., Weissenbach, J., & Goodfellow, P. N. (1994) · Nature Genetics · doi:10.1038/ng0594-22 · Cited by 365
Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas
Nupponen, N. N., Kakkola, L., Koivisto, P., & Visakorpi, T. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65554-x · Cited by 307
Reizer, J., Reizer, A., & Saier, M. H. (1993) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239309086796 · Cited by 280
Three-dimensional organization of a human water channel
Cheng, A., van Hoek, A. N., Yeager, M., Verkman, A. S., & Mitra, A. K. (1997) · Nature · doi:10.1038/42517 · Cited by 276
Use of rituximab, the new FDA-approved antibody
Leget, G. A., & Czuczman, M. S. (1998) · Current Opinion in Oncology · doi:10.1097/00001622-199811000-00012 · Cited by 251
(1996) · PubMed · Cited by 238
Laniado, M., Lalani, E., Fraser, S. P., Grimes, J. A., Bhangal, G., Djamgoz, M. B. A., & Abel, P. D. (1997) · Europe PMC (PubMed Central) · Cited by 201
van Weerden, W. M., de Ridder, C. M., Verdaasdonk, C. L., Romijn, J. C., van der Kwast, T., Schröder, F. H., & van Steenbrugge, G. J. (1996) · Europe PMC (PubMed Central) · Cited by 172
Xenografts of Primary Human Prostatic Carcinoma
Pretlow, T. G., Wolman, S. R., Micale, M. A., Pelley, R. J., Kursh, E. D., Resnick, M. I., Bodner, D. R., Jacobberger, J. W., Delmoro, C. M., Giaconia, J. M., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.394 · Cited by 154
Molecular properties of voltage-gated K+ channels
Dolly, J. O., & Parcej, D. N. (1996) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf02110698 · Cited by 133
Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells
Smith, P., Rhodes, N. P., Shortland, A. P., Fraser, S. P., Djamgoz, M. B. A., Ke, Y., & Foster, C. S. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00050-7 · Cited by 110
Skryma, R. N., Prevarskaya, N. B., Dufy-Barbe, L., Odessa, M. F., Audin, J., & DUFY, B. (1997) · The Prostate · Cited by 104
Molecular and cellular biology of prostate cancer
Lalani, E., Laniado, M., & Abel, P. D. (1997) · Cancer and Metastasis Reviews · doi:10.1023/a:1005792206377 · Cited by 93
Bzdega, T., Turi, T. G., Wróblewska, B., She, D., Chung, H. S., Kim, H., & Neale, J. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062270.x · Cited by 84
MOLECULAR AND FUNCTIONAL DIVERSITY OF K+ CHANNELS
Christie, M. J. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb02331.x · Cited by 66
Murphy, G. P., Greene, T. G., Tino, W. T., Boynton, A. L., & Holmes, E. H. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62198-0 · Cited by 65
Oesterling, J. E. (1992) · JAMA · doi:10.1001/jama.1992.03480160094042 · Cited by 59
Prostate-specific membrane antigen: current and future utility.
Gregorakis, A., Holmes, E. H., & Murphy, G. P. (1998) · PubMed · Cited by 52
Cited by
Ohgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., Chen, J., Sharp, J. J., Fujiwara, Y., Barker, J. E., & Fleming, M. D. (2005) · Nature Genetics · doi:10.1038/ng1658 · Cited by 775
The Steap proteins are metalloreductases
Ohgami, R. S., Campagna, D. R., McDonald, A., & Fleming, M. D. (2006) · Blood · doi:10.1182/blood-2006-02-003681 · Cited by 744
Challita-Eid, P. M., Satpayev, D., Yang, P., An, Z., Morrison, K., Shostak, Y., Raitano, A., Nadell, R., Liu, W., Lortie, D. R., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1313 · Cited by 724
Self-citationAntibody–Drug Conjugates for Cancer Therapy
Hafeez, U., Parakh, S., Gan, H. K., & Scott, A. M. (2020) · Molecules · doi:10.3390/molecules25204764 · Cited by 395
CELL LINES USED IN PROSTATE CANCER RESEARCH: A COMPENDIUM OF OLD AND NEW LINES—PART 1
SOBEL, R. E., & SADAR, M. D. (2005) · Journal of Urology · doi:10.1097/01.ju.0000141580.30910.57 · Cited by 364
Metadata
- Authors
- Hubert, R. S., Vivanco, I., Chen, E., Rastegar, S., Leong, K., Mitchell, S. C., Madraswala, R., Zhou, Y., Kuo, J., Raitano, A. B., Jakobovits, A., Saffran, D. C., & Afar, D. E. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-12-07
- Volume
- 96
- Issue
- 25
- Pages
- 14523-14528
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2001904774
- Cited by
- 351
- References
- 34
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.